THY1 is a prognostic-related biomarker via mediating immune infiltration in lung squamous cell carcinoma (LUSC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

THY1 is a prognostic-related biomarker via mediating immune infiltration in lung squamous cell carcinoma (LUSC)

Published:2024-05-30 Issue:11 Volume:16 Page:9498-9517
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Yi Changsheng¹,Zang Nan²,Gao Limin³,Ren Fang⁴

Affiliation:

1. The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450008, China

2. Henan Provincial Chest Hospital, Zhengzhou University, Zhengzhou 450000, China

3. Department of Obstetrics and Gynecology, First Affiliated Hospital, Shihezi University, Shihezi, Xinjiang 832000, China

4. Department of Obstetrics and Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Publisher

Impact Journals, LLC

Reference46 articles.

1. Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.;Rabe;N Engl J Med,2017

2. Non-small cell lung cancer, version 2.2013.;Jahan;J Natl Compr Canc Netw,2013

3. Lung cancer: current therapies and new targeted treatments.;Paz-Ares;Lancet,2017

4. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.;Diamandis;Nat Clin Pract Oncol,2008

5. Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.;Lung;Int J Cancer,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP